Scientists Reverse Alzheimer's in Lab Studies—Here's Why That Changes Everything

For the first time in over a century of Alzheimer's research, scientists have successfully reversed advanced disease in laboratory studies, achieving complete cognitive recovery in mice. Researchers from Case Western Reserve University discovered that restoring the brain's energy balance can not only prevent Alzheimer's disease (AD) but actually reverse it, even after significant damage has occurred.

How Did Scientists Reverse Alzheimer's Disease?

The breakthrough centers on a cellular energy molecule called NAD+, which naturally declines as we age. In people with Alzheimer's, this decline is even more severe, leaving brain cells unable to perform critical functions needed for survival. The research team, led by Kalyani Chaubey from the Pieper Laboratory, tested whether restoring NAD+ balance could repair brains already badly damaged by advanced Alzheimer's.

Using two different mouse models engineered with human genetic mutations that cause Alzheimer's, the researchers administered a pharmacological agent called P7C3-A20. This compound helps cells maintain proper NAD+ balance under stress without raising levels to dangerous heights that could promote cancer—a key safety distinction from over-the-counter NAD+ supplements.

What Were the Specific Results?

The results were remarkable across multiple measures of brain health and function. Both mouse models showed complete recovery from the major pathological events typically seen in Alzheimer's disease:

• Cognitive Function: Mice fully recovered their memory and thinking abilities, performing as well as healthy mice on cognitive tests
• Brain Pathology: The treatment reversed blood-brain barrier deterioration, reduced neuroinflammation, and restored proper synaptic transmission between brain cells
• Biomarker Normalization: Blood levels of phosphorylated tau 217, a recently approved clinical biomarker for Alzheimer's in humans, returned to normal levels, confirming disease reversal

"We were very excited and encouraged by our results," said Andrew A. Pieper, the study's senior author and professor at Case Western Reserve School of Medicine. "Restoring the brain's energy balance achieved pathological and functional recovery in both lines of mice with advanced Alzheimer's. Seeing this effect in two very different animal models, each driven by different genetic causes, strengthens the new idea that recovery from advanced disease might be possible in people with AD when the brain's NAD+ balance is restored."

Why Does This Discovery Matter for Humans?

This research fundamentally challenges how we think about Alzheimer's disease. For more than a century, the medical community has considered Alzheimer's irreversible, focusing research efforts on prevention or slowing progression rather than recovery. Despite billions of dollars spent on decades of research, there has never been a clinical trial of any drug designed to reverse and recover from Alzheimer's.

The study's findings suggest a paradigm shift may be possible. "The key takeaway is a message of hope—the effects of Alzheimer's disease may not be inevitably permanent," Pieper explained. "The damaged brain can, under some conditions, repair itself and regain function."

The research team emphasized that their pharmacological approach differs significantly from commercially available NAD+ supplements, which animal studies have shown can raise cellular NAD+ to dangerously high levels that promote cancer. Their compound maintains proper NAD+ balance without these risks.

The technology is being commercialized by Cleveland-based company Glengary Brain Health, co-founded by Pieper, with plans to move into carefully designed human clinical trials. The next steps include identifying which aspects of brain energy balance are most important for recovery and investigating whether this approach works for other age-related neurodegenerative diseases.